Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson’s Disease – A Randomized, Placebo-Controlled Trial (Short Title: ProD)
Objective: Objective: To assess the impact of probiotic supplementation on depression symptoms and the gut microbiome in people living with Parkinson’s disease (PwPD). Background: Background:…Impact of manganese exposure on neurobehavioral disorders in rats: Insights into oxidative stress pathways and Parkinsonian syndrome pathophysiology
Objective: This study investigates the correlation between oxidative stress in various neural structures induced by manganese (Mn) and the onset of anxious and depressive behaviours…The Impact of Depression on Information Storage, Consolidation and Evocation Processes in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease without Dementia by Deep Brain Stimulation. Descriptive study of the ESDEPARK Scale.
Objective: To identify the clinical correlation between neurocognitive functioning in memory and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that…Retrospective Analysis of our Supportive Care Clinic and Lifestyle Improvement Fitness Program
Objective: The Supportive Care Clinic and Lifestyle Improvement Fitness (LIFT) program provides multidisciplinary care and online educational resources for our parkinsonian patients. Demographics of patients…Depressive Symptomatology in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia. Descriptive Study of the ESDEPARK Scale.
Objective: To evaluate the frequency of depression in a group of patients diagnosed with IPDWD, assessed by a new ESDEPARK scale that specifically measures depressive…The Impact of Non-Motor Symptoms on Quality of Life in Early Parkinson’s Disease: A Prospective Study
Objective: To assess the prevalence and severity of non-motor symptoms (NMS) in early Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL).…Quality of Life and Depression in Patients with and without Idiopathic Parkinson’s Disease without Dementia.
Objective: To identify the impact of depression on QoL in a group of patients with IPDWD. Background: The Quality of Life (QoL) in patients with…Challenges in the Diagnosis and Management of Functional Movement Disorders in a Developing Nation: Insights from the Philippines
Objective: To systematically analyze patient data to explore the clinical phenotypes, risk factors, management, and outcomes among patients with functional movement disorders (FMD) in the…Integrating the Collaborative Care Mental Health Model into Virtual Parkinson’s Disease Care
Objective: In Parkinson’s Disease (PD), neuropsychiatric symptoms start in the prodromal stage. Increased rates of depression and anxiety in PD have been associated with living…Deciphering differences in Functional Movement Disorders between Children and Adults
Objective: To compare the characteristics of FMDs in children and adults Background: Functional movement disorders (FMDs) exhibit notable differences in phenomenology and treatment responses between…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 36
- Next Page »